In recent years global innovation hubs and biomedical clusters have developed collaborative relationships with biotech companies and universities to expand the entrepreneurial ecosystem and bring biomedical startups to international markets.
Through cross-industry and cross-geography collaborations, early-stage life science startups better qualify for essential funding from non-profit organization, research interchange with universities and business expertise from industry. These factors lead to more robust commercial partnerships.
Ability Level: All
Session ID: 503502